You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 283 No. 6, February 9, 2000 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (19)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Outcome at Age 4 Years in Offspring of Women With Maternal Phenylketonuria

The Maternal PKU Collaborative Study

Susan E. Waisbren, PhD; William Hanley, MD; Harvey L. Levy, MD; Harvey Shifrin, MA; Elizabeth Allred, MA; Colleen Azen, PhD; Pi-Nian Chang, PhD; Sanja Cipcic-Schmidt, Dipl-Psych; Felix de la Cruz, MD; Ramona Hall, MS; Reuben Matalon, MD; Jo Nanson, PhD; Bobbye Rouse, MD; Fritz Trefz, MD; Richard Koch, MD

JAMA. 2000;283:756-762.

Context  Untreated maternal phenylketonuria (PKU) increases risk for developmental problems in offspring. The extent to which this risk is reduced by maternal dietary therapy at various stages of pregnancy is not known.

Objective  To determine whether dietary treatment during pregnancy of women with PKU affects developmental outcomes of offspring.

Design  The Maternal PKU Collaborative Study, an ongoing, longitudinal prospective study begun in 1984.

Setting  A total of 78 metabolic clinics and obstetrical offices in the United States, Canada, and Germany.

Participants  A total of 253 children of women with PKU (n=149), with untreated mild hyperphenylalaninemia (n=33), or without known metabolic problems (comparison group; n=71) were followed up to age 4 years.

Intervention  Women with PKU were offered a low-phenylalanine diet prior to or during pregnancy with the aim of maintaining metabolic control (plasma phenylalanine <=10 mg/dL [<=605 µmol/L]). Women with mild hyperphenylalaninemia, who had plasma phenylalanine levels of no more than 10 mg/dL (605 µmol/L) on a normal diet, were not treated.

Main Outcome Measures  Children's scores on cognitive and behavioral assessments (McCarthy Scales of Children's Abilities, Test of Language Development, Achenbach Child Behavior Checklist, Vineland Adaptive Behavior Scales, and Home Observation for Measurement of the Environment), compared by maternal metabolic status at 0 to 10 weeks', 10 to 20 weeks', and after 20 weeks' gestation.

Results  Scores on the McCarthy General Cognitive Index decreased as weeks to metabolic control increased (r = -0.58; P<.001). Offspring of women who had metabolic control prior to pregnancy had a mean (SD) score of 99 (13). Forty-seven percent of offspring whose mothers did not have metabolic control by 20 weeks' gestation had a General Cognitive Index score 2 SDs below the norm. Overall, 30% of children born to mothers with PKU had social and behavioral problems.

Conclusions  Our data suggest that delayed development in offspring of women with PKU is associated with lack of maternal metabolic control prior to or early in pregnancy. Treatment at any time during pregnancy may reduce the severity of delay.


Author Affiliations: Children's Hospital, Boston, Mass (Drs Waisbren and Levy and Ms Allred); Hospital for Sick Children, Toronto, Ontario (Dr Hanley); National Institute of Child Health and Human Development, Bethesda, Md (Mr Shifrin and Dr de la Cruz); Children's Hospital, Los Angeles, Calif (Drs Azen and Koch and Ms Hall); Children's Hospital, Minneapolis, Minn (Dr Chang); University of Tuebingen, Tuebingen, Germany (Ms Cipcic-Schmidt); University of Texas Medical Branch,Galveston (Drs Matalon and Rouse); Royal University Hospital, Saskatoon, Saskatchewan (Dr Nanson); and Children's Hospital of Reutlingen, Reutlingen, Germany (Dr Trefz).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

February 9, 2000
JAMA. 2000;283(6):817-818.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Current Revolution in Newborn Screening: New Technology, Old Controversies
Tarini
Arch Pediatr Adolesc Med 2007;161:767-772.
ABSTRACT | FULL TEXT  

The Maternal Phenylketonuria International Study: 1984-2002
Koch et al.
Pediatrics 2003;112:1523-1529.
ABSTRACT | FULL TEXT  

Cognitive and Behavioral Development in Maternal Phenylketonuria Offspring
Waisbren and Azen
Pediatrics 2003;112:1544-1547.
ABSTRACT | FULL TEXT  

The Maternal Phenylketonuria Project: A Summary of Progress and Challenges for the Future
Clarke
Pediatrics 2003;112:1584-1587.
ABSTRACT | FULL TEXT  

National Institutes of Health Consensus Development Conference Statement: Phenylketonuria: Screening and Management, October 16-18, 2000
National Institutes of Health Consensus Developmen
Pediatrics 2001;108:972-982.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.